Getting stockpiles ready ... Hmmm .... they also increased manufacturing in the lead up to Remestemcel-L outcome for sr-GVHD "in anticipation" and we all know how that turned out ....
.... surely this time around they are increasing stockpiles based on something concrete from either NIH/FDA or why use words like "anticipation for product launch of remestemcel-L" especially with the ambulance chaser lurking in the background ?
I guess we will know more when they tell us .... I would also add there are a few tidbits in there regardless of some of the comments I have read this morning .... is it earth shattering - not really but it is progress ... GLTAH
Product manufacturing & operating costs and manufacturing commercialization payments were US$8.1 million for the current quarter, the majority being for commercial manufacturing and inventory build in anticipation for product launch of remestemcel-L.
Ann: Appendix 4C Quarterly Activity Report, page-27
-
- There are more pages in this discussion • 255 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.17 |
Change
0.045(4.00%) |
Mkt cap ! $1.335B | |||
| Open | High | Low | Value | Volume |
| $1.13 | $1.18 | $1.13 | $4.980M | 4.315M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 73090 | $1.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.17 | 27903 | 1 |
View Market Depth
| Last trade - 16.10pm 30/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |